Google unveiled an artificial intelligence tool Wednesday that its scientists said would help unravel the mysteries of the human genome — and could one day lead to new treatments for diseases.
The deep learning model AlphaGenome was hailed by outside researchers as a “breakthrough” that would let scientists study and even simulate the roots of difficult-to-treat genetic diseases.
While the first complete map of the human genome in 2003 “gave us the book of life, reading it remained a challenge,” Pushmeet Kohli, vice president of research at Google DeepMind, told journalists. “We have the text,” he said, which is a sequence of three billion nucleotide pairs represented by the letters A, T, C and G that make up DNA.
Photo courtesy of Wikimedia Commons
However “understanding the grammar of this genome — what is encoded in our DNA and how it governs life — is the next critical frontier for research,” said Kohli, co-author of a new study in the journal Nature.
Only around two percent of our DNA contains instructions for making proteins, which are the molecules that build and run the body.
The other 98 percent was long dismissed as “junk DNA” as scientists struggled to understand what it was for.
Photo: Reuters
However this “non-coding DNA” is now believed to act like a conductor, directing how genetic information works in each of our cells.
These sequences also contain many variants that have been associated with diseases. It is these sequences that AlphaGenome is aiming to understand.
A MILLION LETTERS
Photo courtesy of Wikimedia Commons
The project is just one part of Google’s AI-powered scientific work, which also includes AlphaFold, the winner of 2024’s chemistry Nobel.
AlphaGenome’s model was trained on data from public projects that measured non-coding DNA across hundreds of different cell and tissue types in humans and mice. The tool is able to analyze long DNA sequences then predict how each nucleotide pair will influence different biological processes within the cell.
This includes whether genes start and stop and how much RNA — molecules which transmit genetic instructions inside cells — is produced.
Other models already exist that have a similar aim. However they have to compromise, either by analyzing far shorter DNA sequences or decreasing how detailed their predictions are, known as resolution. DeepMind scientist and lead study author Ziga Avsec said that long sequences — up to a million DNA letters long — were “required to understand the full regulatory environment of a single gene.”
And the high resolution of the model allows scientists to study the impact of genetic variants by comparing the differences between mutated and non-mutated sequences.
“AlphaGenome can accelerate our understanding of the genome by helping to map where the functional elements are and what their roles are on a molecular level,” study co-author Natasha Latysheva said.
The model has already been tested by 3,000 scientists across 160 countries and is open for anyone to use for non-commercial reasons, Google said.
“We hope researchers will extend it with more data,” Kohli added.
‘BREAKTHROUGH’
Ben Lehner, a researcher at Cambridge University who was not involved in developing AlphaGenome but did test it, said the model “does indeed perform very well.”
“Identifying the precise differences in our genomes that make us more or less likely to develop thousands of diseases is a key step towards developing better therapeutics,” he explained.
However AlphaGenome “is far from perfect and there is still a lot of work to do,” he added.
“AI models are only as good as the data used to train them” and the existing data is not very suitable, he said.
Robert Goldstone, head of genomics at the UK’s Francis Crick Institute, cautioned that AlphaGenome was “not a magic bullet for all biological questions.”
This was partly because “gene expression is influenced by complex environmental factors that the model cannot see,” he said.
However the tool still represented a “breakthrough” that would allow scientists to “study and simulate the genetic roots of complex disease,” Goldstone added.
The column Taiwan in Time will return to this page on Sunday next week.
Ajay Verma, a consultant gastroenterologist at Kettering general hospital in Northamptonshire, says our gut is a “complex machine.” “It is constantly providing us with the nutrition we need, initially to grow and develop, and then for us to survive, thrive and repair from injury and illness.” How can we keep it functioning well? Put simply: “Make sure what you put into it is balanced, and that you clear out its waste products adequately,” Verma says. “In a general gastroenterology clinic, the most common conditions we see are irritable bowel syndrome (IBS), gastroesophageal reflux disease, inflammatory bowel disease and constipation,” says Nisha
The arithmetic is straightforward and uncomfortable. By the end of 2025, Taiwan had committed itself to a 50-30-20 electricity mix — half natural gas, 30 per cent coal, 20 per cent renewables. The Ministry of Economic Affairs’s (MOEA) own monthly energy reports tell a different story. Natural gas reached 47.8 per cent of generation last year. Coal stood at 35.4 per cent, comfortably above its target ceiling. Renewables came in at 13.1 per cent, well short of the 20 per cent Taipei had pledged a decade earlier. Installed renewable capacity reached roughly half of the 12 gigawatts (GW) the government
Last week US President Donald Trump was asked by a reporter whether he would speak on the phone to the President of Taiwan. “l’ll speak to him. I speak to everybody. We have that situation very well in hand,” Trump said. This marked the second time in a couple of weeks he had said he would talk to the President of Taiwan. In 2016 he famously took a call from then-president Tsai Ing-wen (蔡英文), when he was president-elect. Despite warnings that the apocalypse was nigh because of a phone call, the world quickly forgot about the conversation between two democratically-elected presidents.
May 25 to May 31 Few believed that apples could be cultivated on a commercial scale in Taiwan’s high mountains. When horticulturalist Cheng Chao-hsiung (程兆熊) first proposed the idea in 1955, both American and Taiwanese colleagues dismissed it as implausible, arguing that temperate fruit could not be reliably grown on a subtropical island, especially on rugged terrain. However, it was this terrain in the Central Mountain Range where many Chinese Civil War veterans were resettled in the late 1950s. With limited job prospects and no family in Taiwan, they were placed on cooperative farms aimed toward self-sufficiency. Some say the conditions
RSS